Compare
NutriBand Inc. vs CollPlant Biotechnologies Ltd vs ENvue Medical, Inc. vs Milestone Scientific Inc.
| Latest fiscal year | NutriBand Inc. NTRB | CollPlant Biotechnologies Ltd CLGN | ENvue Medical, Inc. FEED | Milestone Scientific Inc. MLSS |
|---|---|---|---|---|
| Year ended | 2026-01-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $2.04M | $2.37M | $2.55M | $8.97M |
| Revenue growth (YoY) | -4.8% | +360.4% | -0.2% | +4.0% |
| Gross margin | 27.8% (computed) | 64.8% | 6.0% | 71.4% |
| Operating margin | -408.4% | -484.3% | -896.6% | -63.5% |
| Net margin | -404.1% | -484.6% | -712.3% | -63.8% |
| Net income | -$8.23M | -$11.49M | -$18.18M | -$5.72M |
| EPS (Diluted) | -$2.58 | -$0.94 | -$26.69 | -$0.07 |
| Operating cash flow | -$5.13M | -$9.42M | -$9.37M | -$2.92M |
| Free cash flow | -$5.14M | -$9.45M | -$9.43M | -$2.93M |
| Cash & equivalents | $4.57M | $5.59M | $4.22M | $1.11M |
| Total assets | $7.55M | $10.79M | $41.12M | $7.81M |
| Total liabilities | $868.4K | $4.70M | $7.63M | $4.99M |
| Shareholders' equity | $6.68M | $6.08M | $33.50M | $2.81M |
| Return on year-end equity | -123.2% | -188.9% | -54.3% | -203.4% |
| Shares outstanding | 12.16M | 12.80M | 1.10M | 80.45M |
Revenue, most recent five fiscal years
| Fiscal year | NutriBand Inc. | CollPlant Biotechnologies Ltd | ENvue Medical, Inc. | Milestone Scientific Inc. |
|---|---|---|---|---|
| Latest | $2.04M Ended 2026-01-31 | $2.37M Ended 2025-12-31 | $2.55M Ended 2025-12-31 | $8.97M Ended 2025-12-31 |
| 1 year earlier | $2.14M Ended 2025-01-31 | $515.0K Ended 2024-12-31 | $2.56M Ended 2024-12-31 | $8.63M Ended 2024-12-31 |
| 2 years earlier | $2.09M Ended 2024-01-31 | $10.96M Ended 2023-12-31 | $2.28M Ended 2023-12-31 | $9.83M Ended 2023-12-31 |
| 3 years earlier | $2.08M Ended 2023-01-31 | $299.0K Ended 2022-12-31 | $752.0K Ended 2022-12-31 | $8.81M Ended 2022-12-31 |
| 4 years earlier | $1.42M Ended 2022-01-31 | $15.64M Ended 2021-12-31 | $1.70M Ended 2021-12-31 | $10.30M Ended 2021-12-31 |